BLZE vs WST · rev $81.4M vs P/E 35, rev $1.72B
Backblaze Inc (BLZE) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Backblaze Inc (BLZE) is a software - infrastructure company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported BLZE revenue for 2026-06-30 was $81.4M. Net income was -$11.2M. BLZE currently screens at market cap $519.1M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
BLZE currently screens at market cap $519.1M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the BLZE and WST stock pages for the full models.
Not investment advice.